Just in: Adults with moderately to severely active #UlcerativeColitis have a new treatment option. The U.S. FDA has approved our first-in-class treatment for this chronic inflammatory disease. Read more: e.lilly/46D8cwh

We've changed our handle from LillyPad to Eli Lilly and Company so we're easier to find. New handle, same purpose since 1876—create medicines that make life better. #WeAreLilly

Don’t miss this news impacting millions living with chronic kidney disease. Read the results from our Phase 3 clinical trial now.

twitter.com/LillyDiabetes/…

Take a deep dive into #GeneticMedicines , what they can treat, and why they’re becoming the medical mainstream. Listen to the latest podcast episode of The Elixir Factor: e.lilly/2MyKGt6 #WeAreLilly

Loxo@Lilly will present new data for hematologic cancers at this year’s ASH (ASH) Annual Meeting and Exposition in New Orleans. Find out more: e.lilly/3WvrPSr #ASH22

Patients who depend on our medicines are at the heart of everything we do. Lilly’s quarterly results show our pipeline of potential new treatments are taking us into an exciting era. Read more: e.lilly/3TWlBcz

Diverse representation in clinical trials is vital. Lilly is working to address the unique needs of people with skin of color (SOC). Learn more about our new Phase 3 clinical trial — a first-of-its-kind — in atopic dermatitis for people with SOC: e.lilly/3eRxilr

Part of creating medicines is investing in what’s to come. Our continued relationship with Purdue University establishes a new scholarship and recruitment program & extends our research collaboration, strengthening the path to tomorrow’s medicines. Read more: e.lilly/3Ne6xUR

In this episode, we get to know an African American woman who lives with #AtopicDermatitis — who shares the emotional experience of this often misunderstood condition. Learn more in this episode of The Elixir Factor podcast: e.lilly/2MyKGt6 #WeAreLilly

Our latest proposed acquisition could accelerate gene therapies that aim to restore, improve, and preserve hearing for patients living with disabling hearing loss worldwide. Read more here: e.lilly/3ghFlrU

When you’re focused on innovation to save lives, you know a good idea could come from anywhere. In this episode, we discuss our shared innovation space supporting biotechs. Listen to the latest podcast episode of The Elixir Factor now: e.lilly/2MyKGt6 #WeAreLilly

Lilly and the Lilly Foundation are providing critical assistance to help the victims of hurricanes Fiona and Ian. Learn more: e.lilly/3rNla83 #WeAreLilly

The U.S. FDA granted Fast Track designation for a potential Lilly medicine for adults with obesity, or overweight with weight-related comorbidities. Read more e.lilly/3CyMqNz

'We see the disparities and want to change them.” A new Lilly education campaign focuses on Black women and their #breastcancer journey. Read about this innovative campaign: e.lilly/3SFMxw3 #WeAreLilly

A wearable device could make a world of difference — both for #ClinicalTrial patients and for researchers. Don’t miss the second part of our conversation about digital health on the latest podcast episode of The Elixir Factor: e.lilly/2MyKGt6 #WeAreLilly

If you or someone you know has lost Lilly medicine due to the recent hurricanes, please visit our website for information on product replacement or call The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979). e.lilly/3jJp4LC

Clinical trials help develop new treatments that may improve patient lives. In collaboration with Former Account of Eli Lilly and Company, we feel trial diversity is critical to advancing health equity & ensuring treatments may benefit all who use them. Find trials in #CLL bit.ly/3ejyZrf #BCAM2022

Education and awareness about #type1diabetes are crucial to treating it. JDRF launched the #T1DIndex — a first-of-its-kind tool — that will further push the envelope in diabetes research and help make life better for 8.7 million around the world.

twitter.com/JDRF/status/15…

How can we keep a better pulse on the health of #clinicaltrial participants? By continuously monitoring things like heart rate. On this episode of The Elixir Factor, we cover the technology that is helping us better monitor participant safety: e.lilly/2MyKGt6 #WeAreLilly